Iman El-Hariry, Weiwen Ying, Yan Dai, Kevin Foley, Zhengbo Song, Xin Wu, Rong Liang, Jun Zhang, Xiangcai Yang. "A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of RNK08954 in patients with advanced solid tumors with a KRAS G12D mutation.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.2_suppl.729